Sphera Funds Management Ltd. Adma Biologics, Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.8 - $2.56 $1.95 Million - $2.77 Million	-1,081,292 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$2.04 - $3.74 $1.84 Million - $3.38 Million	-903,657 Reduced 45.53%	1,081,292 $2.58 Million
Q2 2020 Aug 13, 2020	BUY	$2.42 - $3.29 $355,374 - $483,133	146,849 Added 7.99%	1,984,949 $5.82 Million
Q1 2020 May 14, 2020	BUY	$1.5 - $4.59 $1.95 Million - $5.96 Million	1,298,100 Added 240.39%	1,838,100 $5.29 Million
Q4 2019 Feb 13, 2020	BUY	$3.89 - $5.15 $2.1 Million - $2.78 Million	540,000 New	540,000 $2.16 Million

339

182M

1.72M

846K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.05B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.